News
Press Center
Boehringer Ingelheim has concluded phase one of their localization effort aimed at manufacturing their innovative thrombolytic medicines in Russia: the first batches of Metalyse (tenectaplase) for acute heart attack treatment were produced at NPO Petrovax Pharm facilities.
More
Topics Petrovax Pharm Speaking at the International Arctic Forum, the company's senior vice president Larisa Zelkova said: «Traditionally, the company invests in the social structures of the territories where it operates. Over the past five years, we have been actively developing grant and competitive programs in Norilsk and the Kola Peninsula. In addition, the company pays attention to the development of social entrepreneurship - the Academy of Social Entrepreneurship, the provision of interest-free loans for social projects».
More
Topics Norilsk Nickel